The presentation will be done by Deborah Yurgelun-Todd, PhD, director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah.
On April 12 during the SupplySide Science Tour being held in Salt Lake City, UT, Kyowa Hakko USA (New York City) will present scientific data on its Cognizin cognitive-health ingredient, which offers benefits such as improved memory, concentration, and focus. The presentation will be done by Deborah Yurgelun-Todd, PhD, director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah.
Part of the presentation will cover the results of a recent six-week study conducted at McLean Hospital that measured and visualized the functional effects of Cognizin on various facets of brain function. Tests performed include a virtual water maze task as well as functional Magnetic Resonance Imaging, with statistical improvements shown in attention, focus, memory, and recall at dosages as low as 500 mg.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Synergistic blend of fructooligosaccharide and L-theanine supports memory in recent study
June 10th 2024A recent study found that the combination of fructooligosaccharide (FOS) and L-theanine, marketed as GBL-Memory from Green Bioactives, based in Edinburgh, Scotland was able to support memory in both animals and humans.